Michael Wayne Kalb

Michael Wayne Kalb (finance chief) discloses dealings in 3 companies, chiefly Amarin CORP Plc\uk, Catalyst Pharmaceuticals, Inc. and CinCor Pharma, Inc. The record holds 80 filings, for trades running from 31 January 2018 to 15 July 2026.

Sales make up the whole of the open-market record (13 sales, €8.6M). The rest of the record consists of 17 share grants and 48 option exercises.

Most recently, on 17 July 2026, the filings show a transaction worth €376k in Catalyst Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.